UNI-EN 4:Lawsuit for alleged infringement of the montelukast patent in Finland
Firma: KRKA, TOVARNA ZDRAVIL D.D.Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 4 | / | 2013 | | ||||||
| Date of issue: | 2013-01-29 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Lawsuit for alleged infringement of the montelukast patent in Finland | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The document is attached. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Montelukast Finland- Appeal decisiion-28 1 2013.pdf Montelukast Finland- Appeal decisiion-28 1 2013.pdf | Lawsuit, motelukast patent | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-01-29 | Jože Colarič | President of the Management Board | |||
Cena akcji Krka
Cena akcji Krka w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Krka aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka.
